Why General Catalyst Is Doubling Down on Health Care Investments

General Catalyst, the 22-year-old Cambridge, Massachusetts-based venture capital firm, has been a contrarian of late in the health care investment community. While many VCs in the first half of 2022 have been pulling back on investments, particularly in the digital health sector, General Catalyst has been doubling down, the American Hospital Association reports.

Roughly a year after closing its first $600 million health care fund, the firm last month launched its $670 million Health Assurance Fund II, focusing on health system partnerships. Meanwhile, General Catalyst continues to build its bench of investors, expert advisers and health system partners.

The latest addition: Marc Harrison, M.D., president and CEO of Intermountain Healthcare, will run its investment platform. He joins Daryl Tol, the former CEO of Altamonte Springs, Florida-based Advent Health, who in June became General Catalyst’s head of health assurance, and Stephen Klasko, M.D., the former Jefferson Health CEO who was named executive-in-residence in February. Read more.

Total
0
Shares
Related Posts
Read More

HHS Settles $100K Ransomware Investigation with Medical Management Co.

On April 22, 2019, Doctors' Management Services filed a breach report with HHS saying that about 206,695 people were affected when their network server was infected with GandCrab ransomware. The initial unauthorized access to the network occurred on April 1, 2017, but Doctors' Management Services didn't detect the intrusion until December 24, 2018, after ransomware was used to encrypt their files. In April 2019, OCR began its investigation.